BUY Concord Biotech Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1–3 months)13 Jul 2026via IDBI Capital Research Calls Telegram
Entry₹1,330Stated
Stop loss₹1,270-4.51% risk
Exit₹1,27023 Jul 2026, 12:07 pm
Stop-loss hit-4.51%
Follow IDBI Capital for new calls(28% target hit, 115 closed calls)Get alertsWatch CONCORDBIO for new buy/sell callsGet alertsSee 1 active Short-term call on CONCORDBIO
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 supporting0 opposing
Supports the BUY call (2)
Nothing found in this tip’s window yet.
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.